Logo image of DNOW

DNOW INC (DNOW) Stock Fundamental Analysis

NYSE:DNOW - New York Stock Exchange, Inc. - US67011P1003 - Common Stock - Currency: USD

15.06  +0.46 (+3.15%)

After market: 15 -0.06 (-0.4%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to DNOW. DNOW was compared to 48 industry peers in the Trading Companies & Distributors industry. DNOW has an excellent financial health rating, but there are some minor concerns on its profitability. DNOW is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year DNOW was profitable.
In the past year DNOW had a positive cash flow from operations.
DNOW had positive earnings in 4 of the past 5 years.
DNOW had a positive operating cash flow in 4 of the past 5 years.
DNOW Yearly Net Income VS EBIT VS OCF VS FCFDNOW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a decent Return On Assets value of 4.97%, DNOW is doing good in the industry, outperforming 62.50% of the companies in the same industry.
With a Return On Equity value of 7.20%, DNOW perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
The Return On Invested Capital of DNOW (7.85%) is better than 64.58% of its industry peers.
DNOW had an Average Return On Invested Capital over the past 3 years of 9.28%. This is in line with the industry average of 9.66%.
Industry RankSector Rank
ROA 4.97%
ROE 7.2%
ROIC 7.85%
ROA(3y)10.2%
ROA(5y)-2.26%
ROE(3y)15.11%
ROE(5y)-3.01%
ROIC(3y)9.28%
ROIC(5y)N/A
DNOW Yearly ROA, ROE, ROICDNOW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

With a Profit Margin value of 3.40%, DNOW perfoms like the industry average, outperforming 52.08% of the companies in the same industry.
DNOW's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 5.40%, DNOW perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
In the last couple of years the Operating Margin of DNOW has grown nicely.
Looking at the Gross Margin, with a value of 22.83%, DNOW is doing worse than 68.75% of the companies in the same industry.
In the last couple of years the Gross Margin of DNOW has grown nicely.
Industry RankSector Rank
OM 5.4%
PM (TTM) 3.4%
GM 22.83%
OM growth 3Y72.3%
OM growth 5Y26.88%
PM growth 3Y123.35%
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y2.57%
DNOW Yearly Profit, Operating, Gross MarginsDNOW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DNOW is destroying value.
DNOW has less shares outstanding than it did 1 year ago.
The number of shares outstanding for DNOW has been reduced compared to 5 years ago.
DNOW has a worse debt/assets ratio than last year.
DNOW Yearly Shares OutstandingDNOW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DNOW Yearly Total Debt VS Total AssetsDNOW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.41 indicates that DNOW is not in any danger for bankruptcy at the moment.
DNOW has a Altman-Z score of 3.41. This is in the better half of the industry: DNOW outperforms 62.50% of its industry peers.
DNOW has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.41
ROIC/WACC0.78
WACC10.07%
DNOW Yearly LT Debt VS Equity VS FCFDNOW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

DNOW has a Current Ratio of 2.32. This indicates that DNOW is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.32, DNOW is doing good in the industry, outperforming 64.58% of the companies in the same industry.
A Quick Ratio of 1.48 indicates that DNOW should not have too much problems paying its short term obligations.
The Quick ratio of DNOW (1.48) is better than 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.48
DNOW Yearly Current Assets VS Current LiabilitesDNOW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for DNOW have decreased by 0.00% in the last year.
Measured over the past years, DNOW shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.83% on average per year.
The Revenue has been growing slightly by 4.74% in the past year.
Measured over the past years, DNOW shows a decrease in Revenue. The Revenue has been decreasing by -4.27% on average per year.
EPS 1Y (TTM)0%
EPS 3Y97.18%
EPS 5Y30.83%
EPS Q2Q%4.76%
Revenue 1Y (TTM)4.74%
Revenue growth 3Y13.29%
Revenue growth 5Y-4.27%
Sales Q2Q%6.39%

3.2 Future

The Earnings Per Share is expected to grow by 6.03% on average over the next years.
Based on estimates for the next years, DNOW will show a small growth in Revenue. The Revenue will grow by 3.50% on average per year.
EPS Next Y-2.07%
EPS Next 2Y1.54%
EPS Next 3Y4.86%
EPS Next 5Y6.03%
Revenue Next Year3.41%
Revenue Next 2Y3.84%
Revenue Next 3Y3.32%
Revenue Next 5Y3.5%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DNOW Yearly Revenue VS EstimatesDNOW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
DNOW Yearly EPS VS EstimatesDNOW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.19 indicates a correct valuation of DNOW.
Based on the Price/Earnings ratio, DNOW is valued a bit cheaper than 77.08% of the companies in the same industry.
DNOW's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.86.
The Price/Forward Earnings ratio is 15.88, which indicates a correct valuation of DNOW.
The rest of the industry has a similar Price/Forward Earnings ratio as DNOW.
The average S&P500 Price/Forward Earnings ratio is at 21.43. DNOW is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.19
Fwd PE 15.88
DNOW Price Earnings VS Forward Price EarningsDNOW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

85.42% of the companies in the same industry are more expensive than DNOW, based on the Enterprise Value to EBITDA ratio.
93.75% of the companies in the same industry are more expensive than DNOW, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.5
EV/EBITDA 8.16
DNOW Per share dataDNOW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.53
EPS Next 2Y1.54%
EPS Next 3Y4.86%

0

5. Dividend

5.1 Amount

DNOW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DNOW INC

NYSE:DNOW (6/26/2025, 8:04:00 PM)

After market: 15 -0.06 (-0.4%)

15.06

+0.46 (+3.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners99.9%
Inst Owner Change-0.55%
Ins Owners2.35%
Ins Owner Change9.16%
Market Cap1.59B
Analysts82.5
Price Target16.83 (11.75%)
Short Float %2.45%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)53%
Min EPS beat(2)24.44%
Max EPS beat(2)81.55%
EPS beat(4)3
Avg EPS beat(4)26.54%
Min EPS beat(4)-1.96%
Max EPS beat(4)81.55%
EPS beat(8)4
Avg EPS beat(8)15.07%
EPS beat(12)8
Avg EPS beat(12)17.81%
EPS beat(16)12
Avg EPS beat(16)50.45%
Revenue beat(2)2
Avg Revenue beat(2)0.54%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.07%
Revenue beat(4)2
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)1.07%
Revenue beat(8)3
Avg Revenue beat(8)-1.59%
Revenue beat(12)7
Avg Revenue beat(12)-0.22%
Revenue beat(16)10
Avg Revenue beat(16)0.12%
PT rev (1m)-13.16%
PT rev (3m)-10%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.54%
EPS NY rev (1m)-0.75%
EPS NY rev (3m)4.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)-1.82%
Valuation
Industry RankSector Rank
PE 16.19
Fwd PE 15.88
P/S 0.66
P/FCF 8.5
P/OCF 7.91
P/B 1.4
P/tB 1.88
EV/EBITDA 8.16
EPS(TTM)0.93
EY6.18%
EPS(NY)0.95
Fwd EY6.3%
FCF(TTM)1.77
FCFY11.76%
OCF(TTM)1.9
OCFY12.64%
SpS22.82
BVpS10.79
TBVpS8.01
PEG (NY)N/A
PEG (5Y)0.53
Profitability
Industry RankSector Rank
ROA 4.97%
ROE 7.2%
ROCE 10.92%
ROIC 7.85%
ROICexc 9.62%
ROICexgc 13.77%
OM 5.4%
PM (TTM) 3.4%
GM 22.83%
FCFM 7.76%
ROA(3y)10.2%
ROA(5y)-2.26%
ROE(3y)15.11%
ROE(5y)-3.01%
ROIC(3y)9.28%
ROIC(5y)N/A
ROICexc(3y)12.28%
ROICexc(5y)N/A
ROICexgc(3y)16.15%
ROICexgc(5y)N/A
ROCE(3y)12.9%
ROCE(5y)N/A
ROICexcg growth 3Y60.02%
ROICexcg growth 5Y23.31%
ROICexc growth 3Y50.38%
ROICexc growth 5Y23.73%
OM growth 3Y72.3%
OM growth 5Y26.88%
PM growth 3Y123.35%
PM growth 5YN/A
GM growth 3Y1.01%
GM growth 5Y2.57%
F-Score7
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 36.84%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 119.64%
Profit Quality 228.05%
Current Ratio 2.32
Quick Ratio 1.48
Altman-Z 3.41
F-Score7
WACC10.07%
ROIC/WACC0.78
Cap/Depr(3y)46.41%
Cap/Depr(5y)37.91%
Cap/Sales(3y)0.51%
Cap/Sales(5y)0.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y97.18%
EPS 5Y30.83%
EPS Q2Q%4.76%
EPS Next Y-2.07%
EPS Next 2Y1.54%
EPS Next 3Y4.86%
EPS Next 5Y6.03%
Revenue 1Y (TTM)4.74%
Revenue growth 3Y13.29%
Revenue growth 5Y-4.27%
Sales Q2Q%6.39%
Revenue Next Year3.41%
Revenue Next 2Y3.84%
Revenue Next 3Y3.32%
Revenue Next 5Y3.5%
EBIT growth 1Y-4.41%
EBIT growth 3Y95.2%
EBIT growth 5Y21.47%
EBIT Next Year72.25%
EBIT Next 3Y25.1%
EBIT Next 5Y20.22%
FCF growth 1Y9250%
FCF growth 3Y126.11%
FCF growth 5Y6.39%
OCF growth 1Y1156.25%
OCF growth 3Y114.96%
OCF growth 5Y5.88%